As GLP-1 supply grows and insurance coverage expands, prices should drop
Current evidence confirms GLP-1 receptors in human retinal neurons, glia, and choroidal endothelium, where they modulate hyperglycemia-induced apoptosis and oxidative stress 39,40,41
Phase 3 trials for obesity drugs typically run 72 to 96 weeks, and the FDA review process adds another 6 to 12 months after submission
Plan for the present and strategize for the future with support from a trusted partner dedicated to your wellness journey
The SDUD is publicly available data provided as part of the Medicaid Drug Rebate Program (MDRP), and provides information on the number of prescriptions, Medicaid spending before rebates, and cost-sharing for rebate-eligible Medicaid outpatient drugs by NDC, quarter, managed care or fee-for-service, and state
Being informed helps you evaluate information critically and confidently